Evidence map›Paper›PMID 32140868›Full record

ArticleJournal of neurology2020

Depression in myasthenia gravis: a heterogeneous and intriguing entity.

Yury V Gavrilov, Tatjana M Alekseeva, Olga A Kreis, Philipp O Valko, Konrad P Weber, Yulia Valko

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Juvenile Myasthenia Gravis in a 14-year-old adolescent masked by mood disorder: the complex balance between neurology and psychiatry.Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology · 2022
    Article
  10. Observational
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yury V GavrilovDepartment of General Pathology and Pathological Physiology, Institute of Experimental Medicine, 197376, St. Petersburg, Russia.
Tatjana M AlekseevaDepartment of Neurology and Psychiatry, Almazov National Medical Research Centre, 197341, St. Petersburg, Russia.
Olga A KreisDepartment of Neurology and Psychiatry, Almazov National Medical Research Centre, 197341, St. Petersburg, Russia.
Philipp O ValkoDepartment of Neurology, University Hospital Zurich, University of Zurich, 8091, Zurich, Switzerland.
Konrad P WeberDepartment of Neurology, University Hospital Zurich, University of Zurich, 8091, Zurich, Switzerland.ORCID http://orcid.org/0000-0003-2526-4582
Yulia ValkoDepartment of Neurology, University Hospital Zurich, University of Zurich, 8091, Zurich, Switzerland. Yulia.Valko@usz.ch.ORCID http://orcid.org/0000-0002-6147-1960

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung [320030_166346]
6 · The paper itself

Abstract

backgroundDepressive symptoms in myasthenia gravis (MG) are common, may mimic other disease features, and contribute to misdiagnosis and diagnostic delay. Nevertheless, the clinical determinants of depressive symptoms in MG remain poorly studied, in particular their overlap with fatigue. Moreover, studies in MG have rarely looked at distinct depression phenotypes.

methodsIn 68 consecutive MG patients, we ascertained cognitive-affective and somatic depression with the Beck Depression Inventory (BDI), and also assessed age at disease onset, education, marital state, work ability, sleepiness, fatigue, and treatment modalities. Disease severity was graded according to the Myasthenia Gravis Foundation of America (MGFA) classification.

resultsThe prevalence of moderate-severe depression was 20.5%. While depression and fatigue showed large overlap (n = 37, 54.4%), only fatigue increased with disease severity, while BDI scores did not. Thymectomy was independently associated with lower BDI scores, but had no impact on fatigue. Total BDI scores were similar in patients with predominantly cognitive-affective and with predominantly somatic depression. However, ESS correlated only with cognitive-affective BDI, and younger age was independently associated with cognitive-affective BDI. Conversely, female sex and thymectomy were independently associated with somatic BDI.

conclusionsDepression and fatigue are highly prevalent and largely overlapping comorbidities in MG, but only fatigue increased with disease severity, and only depression was milder in thymectomized patients. Comparative use of BDI subscales in MG reveals distinct depression phenotypes with distinct correlations to other disease features.

Indexed as

DepressionFatigueMyasthenia GravisThymectomyAdultComorbidityFemaleHumansMaleMiddle AgedPrevalenceRussiaSeverity of Illness IndexBeck Depression InventoryDepressionFatigueMyasthenia gravisThymectomy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.